Patent application number | Description | Published |
20120221009 | MEDICAL DEVICE AND VASCULARIZATION METHOD - A medical device includes a tubular body having a first lumen so designed as to receive a fluid from an opening at one end of the first lumen and discharge the fluid from an opening at the other end of the first lumen, and an expandable body attached to the tubular body. The first lumen communicates with the space inside the expandable body and the expandable body expands by the internal pressure of the fluid which is injected from the opening at one end and enters the space inside the expandable body through the first lumen. | 08-30-2012 |
20120302952 | CATHETER - A catheter includes an outer tube, and an inner tube which is disposed inside the outer tube and through which a guide wire is passed via a distal-side opening and a proximal-side opening. The outer tube has, in the axial direction thereof, at least: a first region on the distal side; a second region disposed on the proximal side and higher in rigidity than the first region; and a transition region which is provided between the first region and the second region and of which rigidity varies from the same rigidity as that of the first rigidity to the same rigidity as that of the second rigidity. The outer tube is configured with an opening, to which the proximal-side opening of the inner tube is connected, being provided in the second region. | 11-29-2012 |
20130178426 | THERAPEUTIC AGENT FOR PULMONARY EMPHYSEMA - The invention has as its object the provision of a medicine capable of reducing a volume of emphysema-suffering pulmonary alveoli or alveolar sacs by means of a respiratory region volume inhibitor containing a coating film formation as a main component and capable of forming a coating film in a respiratory region, characterized by being used in such a way that the coating film-forming component is administered to an emphysema-suffering pulmonary alveolar parenchyma in a human-respiratory region in an amount of 0.004 to 200 g/application, preferably 0.07 to 20 g/application and more preferably 0.5 to 5 g/application on each occasion. | 07-11-2013 |
20130281844 | BIOPSY SYSTEM AND BIOPSY METHOD - A biopsy system includes a tomographic image pick-up device which is insertable into a living body to pick-up a tomographic image of a bioptic target part in the living body to be subjected to biopsy, a guide wire configured to puncture the bioptic target part in the condition where the tomographic image obtained by the tomographic image pick-up device is being observed; and a biopsy device which is inserted along the guide wire to the bioptic target part in the living body after withdrawal of the tomographic image pick-up device out of the living body and by which tissue of the bioptic target part is sampled. The guide wire remains in the living body in the state of puncturing the bioptic target part even after the withdrawal of the tomographic image pick-up device. | 10-24-2013 |
20140319723 | METHOD OF MANUFACTURING A CATHETER TUBE AND CATHETER - A method of making a catheter tube includes extruding a first resin having a first predetermined rigidity through a first extruder; extruding a second resin having a second predetermined rigidity through a second extruder; controlling a mixing ratio of the first and second resins extruded from the first and second extruders; and molding the first and second extruded resins to form an integrally molded tube having at least a first region, a second region which possesses a rigidity greater than the first region, and a transition region between the first region and the second region and which possesses a rigidity varying from the same rigidity as the rigidity of the first region to the same rigidity as the rigidity of the second region. | 10-30-2014 |
20150050257 | FIBROSIS CAUSING AGENT - A fibrosis-causing agent is highly effective in the fibrosis of tissues. The fibrosis-causing agent contains a fibrosis inducer and a fibrosis promoter. A fibrosis-causing agent dosage form and a method of administering the fibrosis-causing agent is also disclosed. | 02-19-2015 |
20150050499 | FIBROSIS CAUSING AGENT - Disclosed herein is a fibrosis-causing agent in a particulate form which effectively reduces the lung capacity in a noninvasive manner. The particulate form effective in reducing lung capacity in a noninvasive manner remains at or on an affected part of the lung to promote and/or induce fibrosis | 02-19-2015 |
20150080792 | OPERATING MEMBER - An object of the present invention is to provide an operating member with which curving operation of a catheter distal part can be easily carried out without moving a comparatively-large member. An operating member has a rotational operation part ( | 03-19-2015 |